首页> 外国专利> Pharmacodynamic combination includes: (a) 10-45 of anesthetics; (b) 0.5-5 of anesthetics; (c) 2-15 of selfless agents; (d) 1-60 of diluents; (e) 0.1-20 of polymers; (f) 0.1-5 of lubricants; (g) 0.05-5 of melts; (h) optional fillers; preparation methods; and use of Tra. Too nervous

Pharmacodynamic combination includes: (a) 10-45 of anesthetics; (b) 0.5-5 of anesthetics; (c) 2-15 of selfless agents; (d) 1-60 of diluents; (e) 0.1-20 of polymers; (f) 0.1-5 of lubricants; (g) 0.05-5 of melts; (h) optional fillers; preparation methods; and use of Tra. Too nervous

机译:药效组合包括:(a)10-45%的麻醉剂; (b)麻醉药的0.5-5%; (c)2-15%的无私代理人; (d)1-60%的稀释剂; (e)0.1-20%的聚合物; (f)0.1-5%的润滑剂; (g)0.05-5%的熔体; (h)可选填料;制备方法;和使用Tra。太紧张了

摘要

Pharmaceutical Combination which comprises (a) alisquireno or a Salt, preferably hemifumarate, Amlodipine or a Salt, (b)Preferably contains procedures; Preparation; and its use for the treatment of hypertension, congestive heart failure, angina, acute myocardial infarction, among others.
机译:药物组合物,其包含:(a)阿拉索卡诺或盐,优选半富马酸盐,氨氯地平或盐,(b)优选包含程序;制备;其用于治疗高血压,充血性心力衰竭,心绞痛,急性心肌梗塞等。

著录项

  • 公开/公告号CL2011000594A1

    专利类型

  • 公开/公告日2011-08-05

    原文格式PDF

  • 申请/专利权人 NOVARTIS AG.;

    申请/专利号CL20110000594

  • 申请日2011-03-21

  • 分类号A61K31/165;A61K31/4422;A61K9/20;A61P9/00;

  • 国家 CL

  • 入库时间 2022-08-21 18:06:59

获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号